Copyright © 2003 by the European Society of Cardiology.
Regular Articles
QR in V1 an ECG sign associated with right ventricular strain and adverse clinical outcome in pulmonary embolism
Cardiology, Swiss Cardiovascular Center Bern, University Hospital, 3010 Bern, Switzerland
* Corresponding author: Nils Kucher, MD, Cardiology, Harvard Medical School, Brigham and Womens Hospital, VTE Research Group, 75 Francis Street, Boston, MA 02115, USA. Tel.: +1-617-732-6986; fax: +1-617-738-7652
E-mail address: nkucher{at}freesurf.ch
Received 11 October 2002; revised 26 November 2002; accepted 27 November 2002
Aims To test the hypothesis that Qr in V1is a predictor of pulmonary embolism, right ventricular strain, and adverse clinical outcome.
Methods and Results ECGs from 151 patients with suspected pulmonary embolism were blindly interpreted by two observers. Echocardiography, troponin I, and pro-brain natriuretic peptide levels were obtained in 75 patients with pulmonary embolism. Qr in V1(14 vs 0 in controls; p<0.0001) and ST elevation in V1
1mV (15 vs 1 in controls; p=0.0002) were more frequently present in patients with pulmonary embolism. Sensitivity and specificity of Qr in V1and T wave inversion in V2for predicting right ventricular dysfunction were 31/97% and 45/94%, respectively. Three of five patients who died in-hospital and 11 of 20 patients with a complicated course, presented with Qr in V1. After adjustment for right ventricular strain including ECG, echocardiography, pro-brain natriuretic peptide and troponin I levels, Qr in V1(OR 8.7, 95%CI 1.456.7; p=0.02) remained an independent predictor of adverse outcome.
Conclusions Among the ECG signs seen in patients with acute pulmonary embolism, Qr in V1is closely related to the presence of right ventricular dysfunction, and is an independent predictor of adverse clinical outcome.
Key Words: Echocardiography electrocardiography pulmonary embolism
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
B. Renaud and A. Ngako Heart-type fatty acid-binding proteins (H-FABP): a reliable tool for initial risk stratification of pulmonary embolism? Eur. Heart J., January 5, 2007; (2007) ehl433v1. [Full Text] [PDF] |
||||
![]() |
B. Ghaye, A. Ghuysen, P.-J. Bruyere, V. D'Orio, and R. F. Dondelinger Can CT Pulmonary Angiography Allow Assessment of Severity and Prognosis in Patients Presenting with Pulmonary Embolism? What the Radiologist Needs to Know RadioGraphics, January 1, 2006; 26(1): 23 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Z. Goldhaber Thrombolytic Therapy for Patients With Pulmonary Embolism Who Are Hemodynamically Stable But Have Right Ventricular Dysfunction: Pro Arch Intern Med, October 24, 2005; 165(19): 2197 - 2199. [Full Text] [PDF] |
||||
![]() |
N. Kucher and S. Z. Goldhaber Management of Massive Pulmonary Embolism Circulation, July 12, 2005; 112(2): e28 - e32. [Full Text] [PDF] |
||||
![]() |
M Riedel Diagnosing pulmonary embolism Postgrad. Med. J., June 1, 2004; 80(944): 309 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. J. Schoepf, S. Z. Goldhaber, and P. Costello Spiral Computed Tomography for Acute Pulmonary Embolism Circulation, May 11, 2004; 109(18): 2160 - 2167. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kucher and S. Z. Goldhaber Cardiac Biomarkers for Risk Stratification of Patients With Acute Pulmonary Embolism Circulation, November 4, 2003; 108(18): 2191 - 2194. [Full Text] [PDF] |
||||




